Skip to main content
SpringerLink
Log in

Adalimumab/etanercept/infliximab

Oral squamous cell cancer: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rahman N, Healy C, Flint SR, Stassen LFA.Cautionary note: A possible association between oral squamous cell carcinoma and tumor necrosis factor antagonists; need for oral screening. JCR: Journal of Clinical Rheumatology 16: 197-199, No. 4, Jun 2010. Available from: URL: http://dx.doi.org/10.1097/rhu.0b013e3181df8932 - Ireland

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/etanercept/infliximab. React. Wkly. 1318, 7–8 (2010). https://doi.org/10.2165/00128415-201013180-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013180-00018

Keywords

Search

Navigation